Does ALIROCUMAB Cause Injection site reaction? 243 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 243 reports of Injection site reaction have been filed in association with ALIROCUMAB (Praluent). This represents 1.1% of all adverse event reports for ALIROCUMAB.
243
Reports of Injection site reaction with ALIROCUMAB
1.1%
of all ALIROCUMAB reports
0
Deaths
8
Hospitalizations
How Dangerous Is Injection site reaction From ALIROCUMAB?
Of the 243 reports, 8 (3.3%) required hospitalization.
Is Injection site reaction Listed in the Official Label?
Yes, Injection site reaction is listed as a known adverse reaction in the official FDA drug label for ALIROCUMAB.
What Other Side Effects Does ALIROCUMAB Cause?
Myalgia (1,571)
Product dose omission (1,354)
Injection site pain (1,220)
Muscle spasms (1,113)
Arthralgia (993)
Fatigue (922)
Pain (892)
Pain in extremity (888)
Product dose omission issue (864)
Injection site bruising (821)
What Other Drugs Cause Injection site reaction?
ETANERCEPT (9,962)
ADALIMUMAB (4,375)
NALTREXONE (4,360)
DUPILUMAB (4,129)
GLATIRAMER (3,317)
IXEKIZUMAB (1,701)
METHOTREXATE (1,663)
TIRZEPATIDE (1,389)
TOCILIZUMAB (1,343)
CERTOLIZUMAB PEGOL (1,253)
Which ALIROCUMAB Alternatives Have Lower Injection site reaction Risk?
ALIROCUMAB vs ALISKIREN
ALIROCUMAB vs ALISKIREN HEMIFUMARATE
ALIROCUMAB vs ALISKIREN\HYDROCHLOROTHIAZIDE
ALIROCUMAB vs ALIZAPRIDE
ALIROCUMAB vs ALLANTOIN